ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VIGL Vigil Neuroscience Inc

2.65
-0.19 (-6.69%)
After Hours
Last Updated: 16:53:08
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Vigil Neuroscience Inc VIGL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.19 -6.69% 2.65 16:53:08
Open Price Low Price High Price Close Price Prev Close
2.84 2.615 2.93 2.65 2.84
more quote information »

Recent News

Date Time Source Heading
4/17/202416:05GLOBEVigil Presents Key Findings from ILLUMINATE & IGNITE Studies..
3/26/202407:05GLOBEVigil Neuroscience Reports Fourth Quarter and Full Year 2023..
3/20/202407:05GLOBEVigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief..
3/13/202407:05GLOBEVigil Announces Upcoming Presentations at 2024 American..
3/12/202407:05GLOBEVigil Neuroscience to Present at Stifel 2024 Virtual CNS..
3/06/202416:25GLOBEVigil Announces Oral Presentation on Small Molecule TREM2..
3/01/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:05GLOBEVigil Presents Poster on Impacts of Misdiagnosis and Genetic..
2/14/202411:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202416:05GLOBEVigil Neuroscience to Present at Guggenheim 6th Annual..
1/11/202410:30EDGAR2Form 8-K - Current report
1/03/202416:30GLOBEVigil Neuroscience Provides 2023 Year-in-Review and..
11/22/202316:05GLOBEVigil Neuroscience to Present at Evercore ISI 6th Annual..
11/16/202316:31EDGAR2Form 8-K - Current report
11/16/202316:05GLOBEVigil Neuroscience Reports Positive Interim Data from Phase..
11/07/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:15EDGAR2Form 8-K - Current report
11/07/202307:05GLOBEVigil Neuroscience Reports Third Quarter 2023 Financial..
10/17/202307:05GLOBEVigil Neuroscience Announces First Participant Dosed in..
10/12/202316:06EDGAR2Form 8-K - Current report
10/05/202316:01GLOBEVigil Neuroscience to Present at Jefferies Inaugural Biotech..
9/26/202307:05GLOBEVigil Neuroscience Receives Positive Opinion from European..
9/13/202307:31EDGAR2Form 8-K - Current report
9/11/202312:00GLOBEVigil Neuroscience Presents VGL101 Complete Phase 1 Data and..
9/08/202316:10EDGAR2Form 8-K - Current report
9/08/202316:05GLOBEVigil Neuroscience Announces Update on its Small Molecule..
9/08/202307:05GLOBEVigil Neuroscience to Present at 2023 Morgan Stanley Global..
8/08/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202307:19EDGAR2Form 8-K - Current report
8/08/202307:05GLOBEVigil Neuroscience Reports Second Quarter 2023 Financial..
8/07/202318:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/07/202318:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/07/202316:05GLOBEVigil Neuroscience Appoints Christopher J. Silber, M.D. as..
6/01/202307:00GLOBEVigil Neuroscience to Present at 2023 Jefferies Global..
5/10/202307:00GLOBEVigil Neuroscience Reports First Quarter 2023 Financial..
5/09/202307:00GLOBEVigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D...
5/08/202307:08GLOBEVigil Neuroscience Launches ALSPAware to Provide Access to..

Your Recent History

Delayed Upgrade Clock